CASSIE HAMPTON: Open Payments
NPI 1780227496 · QUITMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,949 in 94 payments from 17 companies in 2025. Trend: 2023 $374 · 2024 $121 · 2025 $2,949
Food & beverage: $1,769Travel & lodging: $1,181
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 11 | $1,463 |
| GlaxoSmithKline, LLC. | 29 | $416 |
| GENZYME CORPORATION | 11 | $210 |
| AstraZeneca Pharmaceuticals LP | 5 | $173 |
| Regeneron Healthcare Solutions, Inc. | 5 | $119 |
| Grifols USA, LLC | 5 | $115 |
| Shionogi Inc | 4 | $82 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Electromed, Inc. | 6 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
Products named: INSPIRE, DUPIXENT, TRELEGY ELLIPTA, BREZTRI, Prolastin-C Liquid, NUCALA, Fetroja, SMARTVEST.
Industry payments across TX — which companies pay providers there.
